A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumors
2016 ◽
Vol 34
(3)
◽
pp. 329-337
◽
Keyword(s):
Phase I
◽
Keyword(s):
2020 ◽
Vol 19
(5)
◽
pp. 1210-1217
◽